Clinical Trial Update: Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS) [Phase 3]

View source ↗

Summary

A Phase 3 trial update from AstraZeneca on treating hypercholesterolemia in South Asian subjects; the study status is completed, but results are not disclosed i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypercholesterolemia

Snippet

Sponsor: AstraZeneca | Conditions: Hypercholesterolemia, Dyslipidaemia | Phase 3 | Status: COMPLETED